Zevra Therapeutics (ZVRA) Current Leases (2014 - 2026)
Zevra Therapeutics (ZVRA) posted Current Leases of $406000.0 for Q1 2026, down 3.1% on a QoQ basis from $419000.0 in Q4 2025, and down 31.07% year-over-year from $589000.0 in Q1 2025.
Zevra Therapeutics (ZVRA) Current Leases (2014 - 2026) Analysis & Trends
Zevra Therapeutics' Current Leases history runs 13 years deep, the most recent figure standing at $406000.0 for Q1 2026.
- Quarterly Current Leases fell 31.07% year-over-year to $406000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $406000.0 (down 31.07% YoY) and the FY2025 annual result came in at $419000.0, changed 0.24% from the prior year.
- Current Leases was $406000.0 for Q1 2026 at Zevra Therapeutics, down from $419000.0 in the prior quarter.
- Across five years, Current Leases topped out at $596000.0 in Q2 2024 and bottomed at $356000.0 in Q1 2022.
- A 5-year average of $485785.7 and a median of $475000.0 in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases soared 34.83% — and 2026, when it slumped 31.07%.
- Zevra Therapeutics' Current Leases stood at $480000.0 in 2022, then advanced by 13.12% to $543000.0 in 2023, then retreated by 22.65% to $420000.0 in 2024, then declined by 0.24% to $419000.0 in 2025, then retreated by 3.1% to $406000.0 in 2026.
- Business Quant data shows ZVRA's Current Leases at $406000.0 in Q1 2026, $419000.0 in Q4 2025, and $441000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn | 406,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 406,000.00 |
| Dec 31, 2025 | 419,000.00 |
| Sep 30, 2025 | 441,000.00 |
| Jun 30, 2025 | 525,000.00 |
| Mar 31, 2025 | 589,000.00 |
| Dec 31, 2024 | 420,000.00 |
| Sep 30, 2024 | 540,000.00 |
| Jun 30, 2024 | 596,000.00 |
| Mar 31, 2024 | 583,000.00 |
| Dec 31, 2023 | 543,000.00 |
| Sep 30, 2023 | 433,000.00 |
| Mar 31, 2023 | 470,000.00 |
| Dec 31, 2022 | 480,000.00 |
| Mar 31, 2022 | 356,000.00 |
| Dec 31, 2021 | 356,000.00 |
| Sep 30, 2021 | 349,000.00 |
| Jun 30, 2021 | 342,000.00 |
| Mar 31, 2021 | 336,000.00 |
| Dec 31, 2020 | 327,000.00 |
| Sep 30, 2020 | 318,000.00 |